SCHEMBL13305202

SCHEMBL13305202

Bc1cnn2c(NCc3cccnc3)cc(C3CCN(C(=O)Nc4cccc(C#N)c4)CC3)nc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 5/20 0.52
▸ CHEK1 O14757 1/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ USP2 O75604 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ CASP7 P55210 1/20 0.43
▸ OPRM1 P35372 1/20 0.42
▸ OPRD1 P41143 1/20 0.42
▸ CCR2 P41597 1/20 0.41
▸ FAAH O00519 1/20 0.41
▸ VNN1 O95497 1/20 0.40
▸ CYP3A4 P08684 5/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ CCNE1 P24864 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13289145 0.93 GSK3B (0.53) GSK3BCHEK1KMT2AUSP2HPGD
SCHEMBL12953740 0.92 GSK3B (0.64) GSK3BCCNE1CDK2
SCHEMBL13289230 0.87 GSK3B (0.52) GSK3BCHEK1FAAHALDH1A1MAPK1
SCHEMBL14418661 0.87 GSK3B (0.54) GSK3BCHEK1FAAHMAPK1HTT
SCHEMBL14043233 0.87 GSK3B (0.56) GSK3BCHEK1CCNE1CDK2
SCHEMBL12954095 0.86 GSK3B (0.54) GSK3BCHEK1KMT2AMAPK1MEN1
SCHEMBL14043406 0.86 GSK3B (0.56) GSK3BCHEK1FAAHMAPK1HTT
SCHEMBL13289156 0.86 GSK3B (0.56) GSK3BCHEK1KMT2AFAAHMEN1
SCHEMBL13289498 0.86 GSK3B (0.56) GSK3BCHEK1FAAHCCNE1CDK2
SCHEMBL13121485 0.85 GSK3B (0.66) GSK3BCCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537116-B1 PYRAZOLOPYRIMIDINES SUITABLE FOR THE TREATMENT OF CANCER DISEASES SCHERING CORP (US) 2010-06-02 — — EP disclosed
Send feedback